https://www.avient.com/sites/default/files/2023-05/Mevopur Amber for PET Pharma Pkg Application Bulletin_CN _2.pdf
https://www.avient.com/sites/default/files/2024-10/Final 2_Avient Semicondcutor Packaging Case Study Snapshot 2024.pdf
https://www.avient.com/sites/default/files/2022-08/AVNT Aug 2022 Presentation - Jefferies.pdf
AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) AU G U S T 2 0 2 2 DISCLAIMER 2 Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
WHAT WE DO: MATERIAL SCIENCE 5 CUSTOM FORMULATION SUSTAINABILITY FOR A BETTER TOMORROW Revenue From Sustainable Solutions* 2016-2021 $310 205 140 80 75 45 40 20 $915M2021 Sales ($ in millions) *Avient Sustainable Solutions definitions aligned with FTC 2012 Guide for the Use of Environmental Marketing Claims (“Green Guides”) **2020 is Pro Forma to include full year of the Clariant Color business Future Growth Revenue Assumptions From Sustainable Solutions: 8 - 12% 6 S E CO N D Q UART E R 2022 RE S U LT S $122 $134 2021 2022 $0.87 $0.98 2021 2022 Q2 2022 PERFORMANCE (TOTAL COMPANY) 8 Sales Adjusted Operating Income $1,235 $1,302 2021 2022 + 5% Adjusted EPS + 10% + 13% (in millions) (in millions) (+ 10% excluding FX) (+ 16% excluding FX) (+ 20% excluding FX) Q2 2022 SEGMENT PERFORMANCE 9 CAI $624 $649 Sales ($ in millions) SEM Distribution $86 $94 Operating Income + 4% + 9% $404 $443 Sales $24 $27 Operating Income + 10% + 13% (1) $241 $244 Sales $37 $37 Operating Income + 1% Flat (+ 10% excluding FX) (+ 16% excluding FX) (+ 6% excluding FX) (+ 3% excluding FX) Q2 2021 $1,235 $122 Sustainable Solutions 17 7% 7 Healthcare 23 14% 5 Composites (ex Outdoor High Performance) 10 20% 4 Growth in Asia / LATAM 5 3% 1 Other 69 11% 5 Sub-total $1,359 10% $144 Outdoor High Performance Impact (9) (5) Wage Inflation and Overtime (7) Other Supply Chain Costs (2) Clariant Color Integration Synergies 7 Incentives, Other Employee Costs 4 FX (48) (7) Q2 2022 $1,302 5% $134 Q2 2022 SALES AND OPERATING INCOME (TOTAL COMPANY) 10 Sales Growth Rate Adjusted Operating Income$ millions Adjusted EBITDA Q2 EBITDA BRIDGE 11 Price increases more than offsets raw material and supply chain impacts Q2 2021 $ 159 Demand (29) $ millions CAI: Price / Mix 87 Inflation (58) SEM: Price / Mix 36 Inflation (24) Distribution: Price / Mix 45 Inflation (41) Net Price Benefit 45 Wage Inflation and Overtime (7) Other Supply Chain Costs (2) Clariant Color Integration Synergies 7 Incentives, Other Employee Costs 4 FX (7) Q2 2022 $ 170 China Lockdowns / Russia Impact $ (14) Outdoor High Performance (5) Transportation (5) 12 Q2 '21 Adjusted EPS 0.87$ Color, Additives and Inks 0.11 Specialty Engineered Materials 0.01 Distribution 0.03 Corporate Costs 0.01 F/X (0.05) Segment OI 0.11$ Interest Expense 0.03 Tax Rate (0.03) Q2 '22 Adjusted EPS 0.98$ Q2 EPS BRIDGE Key Updates • Provided progress on 2030 Sustainability Goals • Emphasized commitment to U.N.
EPS (ex Amort) 3.96$ 0.13$ 4.09$ (0.58)$ 3.51$ Pro Forma Leverage (12/31/2022E) Net Debt / Adjusted EBITDA 1.6x 3.4x 2.8x Forecast Dyneema Forecast + Dyneema Sale of Distribution Pro Forma 2022 TWO-YEAR LEVERAGE MODEL 20 3.5x 2.7x 1.6x 2.8x 2.4x 2.0x 2019PF 2020PF 2022E 2022PF 2023E 2024E Dyneema® AcquisitionClariant Color Acquisition (1) Pro forma for the acquisition of the Clariant Color business (2) Pro forma for the acquisition of Dyneema® and potential divestiture of Distribution, including repayment of senior notes due 2023 and Term Loan (1) (1) (2) OUR SPECIALTY JOURNEY CONTINUES 21 • Dyneema® brings leading technology and brand with the World’s Strongest Fiber™, deep history of application development and strong management team focused on specialty applications • Dyneema® transaction is aligned with our previously stated acquisition goal of expanding our composites and fiber capabilities • Similar to our other technology expansion acquisitions, Dyneema® allows us to leverage our invest-to-grow strategy • The possible sale of our Distribution business also presents potential benefits with respect to leverage and EBITDA margins 7% 46% 66% 86% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2015 2021 2022 PF % o f A dj us te d EB IT D A(1 ) JVs Distribution Performance Products & Solutions Specialty (1) Adjusted EBITDA is EBITDA excluding corporate costs and special items (2) Pro forma for the acquisition of Dyneema® and potential divestiture of Distribution (2) Healthcare 4% Packaging 8% Consumer 10% Building & Construction 43% Industrial 15% Transportation 14% Energy 4% Telecom. 2% 2006 2022 Pro forma Healthcare 8% Packaging 23% Consumer 21% Building & Construction 10% Industrial 15% Transportation 9% Energy 4% Telecom. 4% Defense 6% END MARKET TRANSFORMATION TO LESS CYCLICAL INDUSTRIES (W ITH DY N EEM A , EX .
https://www.avient.com/knowledge-base/article/overmolding-part-design
Spiral flow test performed using 0.0625" x 0.375" channel at 400°F
https://www.avient.com/news/polyone-showcases-more-materials-healthcare-applications-mdm-west-2019
Colorant Chromatics™ High Temperature Formulations and Color Concentrates: High-temperature (above 300°F/150°C) polymers and colorant / functional additive packages for healthcare applications
https://www.avient.com/news/white-new-white-polyone-launches-wilflex-universal-white-ink-textile-screen-printing
Featuring excellent opacity and low-temperature (260-280°F, 127-138°C) cure bleed resistance, EPIC Single LC White can also help avoid ghosting on cotton substrates when hot stacking garments.
https://www.avient.com/news/new-compl-t-pke-materials-offer-additional-sustainable-alternatives-polyamides
This development represents a proactive response to demands from our customers in oil & gas, transportation, and industrial industries looking for next-generation engineered materials with a property retention as low as -22°F for pipes, tubing, fluid management, and more,” said Eric Wollan, general manager, PlastiComp at Avient.
https://www.avient.com/sites/default/files/2020-09/versaflex-pf-final.pdf
VersaflexTM PF Versaflex PF VOC Versaflex PF VERSAFLEX PF VOC 39 LDPE / 13 Versaflex PF VERSAFLEX PF 39 LDPE / 13 Versaflex PF N /2 5 m m N /2 5 m m F = 25 ° C 7 I = 25 ° C 20 MD6741 / MD6700 VERSAFLEX PFTM +86 021 60284888 www.avient.com VERSAFLEX™ PF 1 CF6751 PP 2 2420K LDPE Versaflex™ PF MD6727 Versaflex™ PF MD6741 Versaflex™ CF 6751 Versaflex™ PF MD6649 Versaflex™ PF 9512 Versaflex™ CF 8888N-A Versaflex™ PF MD6666 Versaflex™ PF MD6748 Versaflex™ PF MD6700 Versaflex™ CF 9000 PP PVC Tg (°C) -26 -43 -30 -26 -5 1 -6 0 5 / (Shore A) 50 49 35 37 38 35 37 31 30 19 MFI (190°C, 2.16kg) (g/10min) / / / 15 5 15 20 3 5 27 MFI (230°C, 2.16kg) 8 20 8 / / / / / / / 1 LDPE 2420k2/LDPE 2420k/Versaflex™ =4.5/4.5/1 ; =50um (N/25mm) 25°C 20 1.3 1.8 7.9 2.5 2.2 2.7 3.3 3.0 3.7 4.3 75°C 7 5.7 2.9 7.2 3.1 4.0 4.3 4.3 5.5 5.6 / PMMA (N/25mm) 25°C 20 1.8 2.0 7.2 2.6 2.8 3.0 3.6 3.3 3.9 4.9 75°C 7 5.5 4.7 7.1 3.5 / 4.7 6.5 5.8 6.9 /
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Functional Additives Medical Devices Application Bulletin_CN _2_.pdf
Mevopur Healthcare Functional Additives Medical Devices Application Bulletin_CN12.15-2
https://www.avient.com/knowledge-base/article/overmolding-part-design?rtype[]=1164
Spiral flow test performed using 0.0625" x 0.375" channel at 400°F